Rs Robin Robinett

RS Robin Robinett is a seasoned professional with extensive experience in business analysis and technical writing within the biopharmaceutical sector. Currently serving as a Business Analyst and Information Architect at ArborSys Group since July 2017, Robinett excels in developing innovative strategies and structured content-management models tailored to clients' needs. Previous roles at Merck include Senior Consultant in medical writing, Director of Biologics and Vaccine Technical Writing, and Director of BioProcess CMC, where key contributions involved managing processes for regulatory documentation and enhancing team capabilities. With a rich academic background including a PhD and MS in Chemical Engineering from Lehigh University and dual BS degrees in Biochemistry and Chemical Engineering from the University of Missouri-Columbia, Robinett combines technical expertise with a robust understanding of regulatory requirements.